Unlock instant, AI-driven research and patent intelligence for your innovation.

L-isoleucine genetic engineering production bacteria

A technology for producing isoleucine and bacteria, which is applied in the field of genetic engineering, can solve the problems that the production cannot meet the market demand and the low acid production capacity, and achieve wide industrial application prospects, effective accumulation, increase production and sugar-acid conversion rate Effect

Active Publication Date: 2019-01-18
SHANGHAI RES & DEV CENT OF INDAL BIOTECH +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, domestic manufacturers have produced L-isoleucine in batches, but the strains used by these manufacturers have low acid production capacity, and the output cannot meet market demand.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • L-isoleucine genetic engineering production bacteria
  • L-isoleucine genetic engineering production bacteria
  • L-isoleucine genetic engineering production bacteria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1 : Construction of plasmid pMW-ilvGAM

[0054] 1.1. Construction of pMW-ilvGMEDA

[0055] The pMW119 vector (purchased from Nippon Gene Company) was digested with HindIII / EcoRI to recover a 4.1kb fragment; using the MG1655 genome as a template and ilvG119F / ilvG119R as primers, PCR amplified the ilvGMEDA fragment, about 9kb; the above fragment was GIBSON ligated ( Referring to Enzymatic assembly of DNA molecules up to several hundred kilobases, Daniel G Gibson, et al. Nature Methods. 2009), the pMW-ilvGMEDA plasmid was obtained.

[0056] 1.2. Construction of pMW-ilvGAM

[0057] Using the pMW-ilvGMEDA plasmid as a template and using PilvGMF / ilvAMF as primers, PCR amplified yifB and pMW119 vector fragments, about 7kb; using ilvGMR / ilvAMR as primers, PCR amplified part of the ilvGMEDA fragment, about 6.2kb; using ilvGMF / PilvGMR As a primer, a partial fragment of ilvG, about 1.1kb, was amplified by PCR; the above fragment was connected with GIBSON to obtain the ...

Embodiment 2

[0058] Example 2 : Obtaining of L-isoleucine expression strain

[0059] The pMW-ilvGAM plasmid obtained in Example 1.2 was transferred into the competent cells of the L-threonine-producing bacteria CCTCC M 2015556 (for specific methods of preparation and transformation of competent cells, refer to "Molecular Cloning Experiment Guide" (third edition), J. Sam Brook, edited by D.W. Russell (U.S.), translated by Huang Peitang, etc., Science Press, Beijing, 2002, page 96 of the first chapter), obtained the genetically engineered bacteria CIBTS1800 for producing L-isoleucine , whose genotype is MG1655(Δtdh,ΔthrL,thrA*(G433R),Ptac-rhtC,lysC*(T342I),ΔtdcC,ΔdacA::thrA*BC,ΔyihF::thrA*BCΔcadB::Thr,ΔyidJ::Thr ) / pMW-ilvGAM.

Embodiment 3

[0060] Example 3 : Fermentation of L-isoleucine genetically engineered bacteria to produce L-isoleucine

[0061] Utilize the L-isoleucine genetically engineered bacterium to produce the method for L-isoleucine by fermentation as follows:

[0062] A single colony was picked and inoculated in 400 μl of a 96-well plate containing ampicillin fermentation medium, and cultured at 37° C. and 290 rpm for 40 hours.

[0063] After the fermentation was finished, the L-isoleucine content in the supernatant of the fermentation broth was determined by HPLC, and the results are shown in Table 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an L-isoleucine production strain constructed through genetic engineering. The production strain is collected in the China Center for Type Culture Collection (CCTCC), with collection number of CCTCC M 2015557. The L-isoleucine production strain can realize effective accumulation of L-isoleucine in fermentation liquor in the fermentation process, has higher L-isoleucine yield and saccharic acid conversion rate, is low in production cost and has an extensive industrial application prospect.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and in particular relates to an L-isoleucine genetic engineering production bacterium. Background technique [0002] L-isoleucine, chemical name L-α-amino-γ-methylpentanoic acid, is a non-polar, water-transporting amino acid of the aspartic acid family, and one of the eight essential amino acids for the human body. It has the effect of promoting protein synthesis and inhibiting decomposition. Adults need to ingest 20mg / kg (body weight) of L-isoleucine from outside every day. Therefore, L-isoleucine has extensive commercial value in the fields of food, medicine, feed and sports health care. [0003] Since isoleucine has two asymmetric carbon atoms, it is difficult to produce by chemical synthesis and the cost is very high. The production of L-isoleucine by biotransformation is biosynthesis using α-aminobutyric acid and α-oxobutyric acid as precursor materials, but due to expensive r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/21C12P13/06C12R1/19
Inventor 杨晟蒋宇陈飚
Owner SHANGHAI RES & DEV CENT OF INDAL BIOTECH